MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

Search

Dynavax Technologies Corp

Închisă

SectorSănătate

10.27 1.58

Rezumat

Modificarea prețului

24h

Curent

Minim

10.2

Maxim

10.3

Indicatori cheie

By Trading Economics

Venit

-103M

-96M

Vânzări

-3.9M

68M

P/E

Medie Sector

58.75

40.527

Marjă de profit

-140.982

Angajați

405

EBITDA

-106M

-94M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+114.22% upside

Dividende

By Dow Jones

Următoarele câștiguri

5 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-477M

1.2B

Deschiderea anterioară

8.69

Închiderea anterioară

10.27

Sentimentul știrilor

By Acuity

44%

56%

95 / 375 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

Dynavax Technologies Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

5 iul. 2025, 04:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4 iul. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

4 iul. 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4 iul. 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

4 iul. 2025, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

4 iul. 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

4 iul. 2025, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

4 iul. 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4 iul. 2025, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

4 iul. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4 iul. 2025, 15:57 UTC

Market Talk

Base Metal Prices Fall in Thin, Risk-off Trading -- Market Talk

4 iul. 2025, 15:49 UTC

Market Talk

Gold Futures Set to End Week Flat After Mixed Jobs Report -- Market Talk

4 iul. 2025, 15:49 UTC

Achiziții, Fuziuni, Preluări

Credit Agricole: Deal Will Have a Negative Impact of Approximately 30 Basis Points on the Fully-Loaded CET1 Ratio

4 iul. 2025, 15:49 UTC

Achiziții, Fuziuni, Preluări

Credit Agricole: Transaction Is Consistent With Targets in Terms of Return of Investment, Return on Tangible Equity

4 iul. 2025, 15:49 UTC

Achiziții, Fuziuni, Preluări

Credit Agricole Received All Required Authorizations

4 iul. 2025, 15:48 UTC

Achiziții, Fuziuni, Preluări

Credit Agricole: CACEIS and Santander Are Maintaining Their Long-Term Partnership

4 iul. 2025, 15:47 UTC

Achiziții, Fuziuni, Preluări

Credit Agricole: Agreement Was Announced on Dec. 19

4 iul. 2025, 15:47 UTC

Achiziții, Fuziuni, Preluări

Credit Agricole Now Controls 100% of the Share Capital of CACEIS

4 iul. 2025, 15:46 UTC

Achiziții, Fuziuni, Preluări

Credit Agricole Completes Acquisition of Santander's 30.5% Stake in CACEIS

4 iul. 2025, 14:30 UTC

Achiziții, Fuziuni, Preluări

Rocky Shore Closes Hemlo Area Claims Sale to Barrick Mining Unit for C$975,000 Cash

4 iul. 2025, 13:53 UTC

Market Talk

Polish Zloty Faces Hit From Prospect of Further Rate Cuts -- Market Talk

4 iul. 2025, 13:41 UTC

Market Talk

Japanese Yen Could Receive Boost From Increased Rate-Hike Bets -- Market Talk

4 iul. 2025, 13:41 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

4 iul. 2025, 13:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

4 iul. 2025, 12:37 UTC

Market Talk

Fund Manager Roundup: U.S. Treasurys in Focus Amid Rising Debt

4 iul. 2025, 12:37 UTC

Market Talk

Fund Manager Roundup: U.S. Treasurys in Focus -2-

4 iul. 2025, 12:30 UTC

Market Talk

Fund Manager Roundup: U.S. Tariff Deadline Key for Dollar Outlook, U.K. Fiscal Risks In Focus for Pound

4 iul. 2025, 12:15 UTC

Market Talk

Targeted Tariffs Would Likely Support Dollar -- Market Talk

4 iul. 2025, 12:13 UTC

Market Talk

Further Pause in Tariffs Would Have Unclear Impact on Dollar -- Market Talk

4 iul. 2025, 12:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Comparație

Modificare preț

Dynavax Technologies Corp Așteptări

Obiectiv de preț

By TipRanks

114.22% sus

Prognoză pe 12 luni

Medie 22 USD  114.22%

Maxim 31 USD

Minim 10 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruDynavax Technologies Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

4 ratings

3

Cumpărare

0

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

9.62 / 10.9Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Termen mediu

Very Strong Bearish Evidence

Termen lung

Strong Bearish Evidence

Sentiment

By Acuity

95 / 375 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Dynavax Technologies Corp

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.